NSUP
RDY icon

NLB Skladi upravljanje premozenja’s Dr. Reddy's Laboratories RDY Stock Holding History

NLB Skladi upravljanje premozenja’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$345K Sell
23,804
-10,000
-30% -$135K 0.01% 326
2026
Q1 		$468K Hold
33,804
– – 0.02% 286
2025
Q4 		$475K Buy
+33,804
New +$474K 0.02% 288

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

NLB Skladi upravljanje premozenja's RDY Position: Q2 2026 in Review

NLB Skladi upravljanje premozenja reduced its Dr. Reddy's Laboratories (RDY) stake by 30% in Q2 2026, selling an estimated $135K and leaving 23,804 shares worth $345K. The position accounts for 0.01% of the portfolio, ranked #326.

NLB Skladi upravljanje premozenja first reported a position in RDY in Q4 2025 and has held it in 3 quarters since. The position peaked at $475K in Q4 2025. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • NLB Skladi upravljanje premozenja held 23,804 shares of Dr. Reddy's Laboratories worth $345K as of Q2 2026.
  • NLB Skladi upravljanje premozenja sold 10,000 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $135K.
  • Dr. Reddy's Laboratories made up 0.01% of NLB Skladi upravljanje premozenja's portfolio in Q2 2026, its #326 holding.
  • NLB Skladi upravljanje premozenja first reported a position in Dr. Reddy's Laboratories in Q4 2025 and has held it in 3 quarters since.
  • NLB Skladi upravljanje premozenja's Dr. Reddy's Laboratories position peaked at $475K in Q4 2025.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on NLB Skladi upravljanje premozenja's 13F filing for Q2 2026, filed 6 Aug 2026.